Pharma-Bio Serv Announces Special Dividend

Rhea-AI Summary

Pharma-Bio Serv (OTCQB:PBSV) has announced a Special Dividend of $0.075 per share, payable on or about April 14, 2023. This dividend is for shareholders of record as of the close of business on March 29, 2023. The company offers consulting services in regulatory compliance to various industries, including pharmaceuticals and biotechnology, mainly in Puerto Rico, the United States, Europe, and Latin America. The announcement reflects the company's commitment to returning value to its shareholders.

Positive

• Approval of a Special Dividend of $0.075 per share.
• Dividend payment set for April 14, 2023, enhancing shareholder returns.

Negative

• None.

DORADO, PUERTO RICO / ACCESSWIRE / March 1, 2023 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device, cosmetic, food and allied products industries, today announced that the Board of Directors approved a Special Dividend of $0.075 per share for shareholders. The Special Dividend will be payable on or about April 14, 2023 to shareholders of record at the close of business on March 29, 2023.

About Pharma-Bio Serv, Inc.

Pharma-Bio Serv services the Puerto Rico, United States, Europe and Latin America markets. Pharma-Bio Serv's core business is FDA and international agencies regulatory compliance consulting related services. The Company's global team includes leading engineering and life science professionals, quality assurance managers and directors.

Forward-Looking Statements

This news release contains "forward-looking statements" within the meaning of the U.S. federal securities laws, which statements may include information regarding the plans, intentions, expectations, future financial performance, or future operating performance of Pharma-Bio Serv. Forward-looking statements are inherently subject to significant business risks, economic uncertainties, and competitive uncertainties, and other factors, which could cause Pharma-Bio Serv's actual results or performance to differ materially from what may be expressed or implied in the forward-looking statements. Important factors that could cause Pharma-Bio Serv's actual results or performance to differ materially from the forward-looking statements include those set forth in the "Risk Factors" section of Pharma-Bio Serv's Annual Report on Form 10-K for the year ended October 31, 2022, and in its other filings with the Securities and Exchange Commission, which filings are available on www.sec.gov. Pharma-Bio Serv disclaims any intention or obligation to update or revise any forward-looking statements to reflect subsequent events and circumstances, except to the extent required by applicable law.

Company Contact:

Pedro J. Lasanta
Chief Financial Officer
787 278 2709

SOURCE: Pharma-Bio Serv, Inc.

View source version on accesswire.com:
https://www.accesswire.com/741422/Pharma-Bio-Serv-Announces-Special-Dividend

FAQ

What is the amount of the Special Dividend announced by Pharma-Bio Serv?

The Special Dividend is set at $0.075 per share.

When will the Special Dividend be paid to shareholders?

The dividend will be payable on or about April 14, 2023.

What date is the record for shareholders to receive the Special Dividend?

Shareholders must be on record by the close of business on March 29, 2023.

How does the Special Dividend benefit shareholders of Pharma-Bio Serv?

It provides direct financial returns to shareholders, reflecting the company's commitment to shareholder value.